| Product |
CAS |
Molecular formula |
More |
| Moxifloxacin, hydrochloride monohydrate |
192927-63-2 |
C21H27ClFN3O5 |
More |
| 2-Methyl-2-propanyl (2-{[(e)-{5-hydroxy-1-[4-(trifluoromethyl)phenyl]p |
192876-03-2 |
C19H27F3N2O4 |
More |
| (5E)-5-[(2-aminoethoxy)imino]-5-[4-(trifluoromethyl)phenyl]-1-pentanol |
192876-02-1 |
C14H19F3N2O2 |
More |
| (2S)-n-[(4s)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diph |
192725-39-6 |
C37H46N4O6 |
More |
| 4-Nitrophenyl anthranilate |
19176-60-4 |
C13H10N2O4 |
More |
| Dibenzo(a,c)triphenylene |
191-68-4 |
C26H16 |
More |
| 10-Oxo mirtazapine (mirtazapine impurity f) |
191546-97-1 |
C17H17N3O |
More |
| 1-Oxo mirtazapine (mirtazapine impurity c) |
191546-96-0 |
C17H17N3O |
More |
| N-[4-[(pyridin-2-ylamino)sulfonyl]phenyl]-acetamide |
19077-98-6 |
C13H13N3O3S |
More |
| N-desmethyl topotecan |
190710-79-3 |
C22H21N3O5 |
More |
| Sodium {1-[({(1s)-1-{3-[(e)-2-(7-chloro-2-quinolinyl)vinyl]phenyl}-3-[ |
190078-45-6 |
C35H35ClNNaO3S |
More |
| Phenyltrimethylammonium hydroxide |
1899-02-1 |
C9H15NO |
More |
| Dibenzo(a,h)pyrene |
189-64-0 |
C24H14 |
More |
| Bis(tetra-n-butylammonium) bis(maleonitriledithiolato) nickel complex |
18958-57-1 |
C40H72N6NiS4 |
More |
| 7-[(2-Aminoethyl)amino]-n,n-dimethyl-2,1,3-benzoxadiazole-4-sulfonamid |
189373-41-9 |
C10H15N5O3S |
More |
| 3A-amino-3a-deoxy-(2as,3as)-gamma-cyclodextrin hydrate |
189307-64-0 |
C48H81NO39 |
More |
| 1,8-Diiodoanthracene |
189105-78-0 |
C14H8I2 |
More |
| 1-O-({1-[({(1r)-1-{3-[(e)-2-(7-chloro-2-quinolinyl)vinyl]phenyl}-3-[2- |
188717-17-1 |
C41H44ClNO9S |
More |
| 4-Hydroxy valsartan, mixture of diastereomers |
188259-69-0 |
C24H29N5O4 |
More |
| 1-[(3,3-Diphenylpropyl)(methyl)amino]-2-methyl-2-propanyl methyl 2,6-d |
187731-34-6 |
C36H42ClN3O6 |
More |
